Use this picture-packed review to discern the many faces of psoriasis, to distinguish the dermatologic disorder from other skin conditions, and to choose the best treatment option.
DR. WONG and DR. ROGERS are dermatologists with Children's Hospital Medical Centre, New South Wales, Australia. They have nothing to disclose in regard to affiliations with, or financial interests in, any organization that may have an interest in any part of this article.
Staff editors: SUZANNE WOLFE, Managing Editor, and JOHN BARANOWSKI, Editor, Contemporary Pediatrics
The authors, manuscript reviewers, and staff editors have nothing to disclose in regard to affiliations with, or financial interests in, any organization that may have an interest in any part of this article.
The precise incidence of childhood psoriasis is difficult to determine because "psoriasis" is not clearly defined. It is well established, however, that the incidence among boys and girls in the pediatric population is roughly equal.1 The disease can develop at any age; peak age of onset is between 15 and 25 years.3,4
Between 30% and 50% of patients with psoriasis have a positive family history for the condition.1,5,6 Psoriasis is a polygenetic disease with contributing environmental factors. Predisposing genetic influences include association with certain human leukocyte antigens (HLA), especially the HLA class 1 antigen Cw6.7 Chromosome 6 is thought to carry a major susceptibility gene to psoriasis.7 Streptococcal infection of the throat or perianal area commonly precipitates childhood psoriasis, especially the guttate type.
Clinical features
Recognize & Refer: Hemangiomas in pediatrics
July 17th 2019Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.
Worsening severity of AD in children associated with increased comorbidity onset risk
November 27th 2023Of patients in the atopic dermatitis (AD) cohort, 36.6% developed at least 1 comorbidity amid follow-up compared to 28.5% in the non-AD reference cohort, investigators of a Sweden, nationwide, population-based cohort study found.
A 13-year-old girl with well-demarcated rash on back and chest
October 19th 2023A healthy 13-year-old girl presented with a 1-month history of an asymptomatic, well-demarcated rash on her back and upper chest. The eruption consisted of discrete, dark brown papules that coalesced into large, flat-topped plaques with mild superficial scale and accentuation of skin markings. What's the diagnosis?
Tapinarof cream 1% reduces itch as early as 24 hours after application for pediatric AD
October 13th 2023A rapid reduction in pruritis as early as 24 hours after first application was announced as new positive data from a pair of identical, phase 3 studies of tapinarof cream 1% in children as young as 2 years and adults with atopic dermatitis (AD).